“Life Science-Related Investigations at the US International Trade Commission,” Jenner & Block Webinar

On August 12, Jenner & Block Partners Mark Davis and Ronald J. Pabis and Associate Susan A. O’Brien will present a CLE webinar on life science-related investigations at the US International Trade Commission (ITC). Partner Louis E. Fogel will moderate the discussion. The program will examine the use of ITC Section 337 investigations for life sciences products, including pharmaceuticals and medical devices. The presenters will cover important issues arising in such cases, including the use of public interest factors, indirect infringement, design around alternatives, the substantive elements of proof, and the procedure used by the ITC in these types of investigations. The program will begin at 12 pm ET. Please email dl_webinar@jenner.com if you are interested in attending. Space is limited. Mr. Davis is co-chair of the ITC Section 337 Practice. He represents multinational, domestic, and start-up companies regarding intellectual property and related international trade, data privacy, unfair competition, and antitrust matters. He has litigated disputes before US district courts throughout the country and the Court of Appeals for the Federal Circuit and has been involved in more than 100 section 337 investigations before the ITC. Mr. Fogel is co-chair of the Life Sciences Practice and a member of the Patent Litigation and Counseling Practice. He represents clients on a range of intellectual property matters, with an emphasis on patent and trade secret litigation. Mr. Fogel’s litigation experience spans a wide array of technologies and industries, including biological drugs, pharmaceuticals, medical devices, chemicals, consumer electronics, and telecommunications. Mr. Pabis is co-chair of the ITC Section 337 Practice. He represents technology companies in patent litigation and patent licensing disputes at all stages of the litigation process. In addition, he has handled and tried a number of Section 337 investigation hearings before the ITC. Ms. O’Brien is an associate in the firm’s Litigation Department and the Patent Litigation and Counseling Practice.

“Life Science-Related Investigations at the US International Trade Commission,” Jenner & Block Webinar

On August 12, Jenner & Block Partners Mark Davis and Ronald J. Pabis and Associate Susan A. O’Brien will present a CLE webinar on life science-related investigations at the US International Trade Commission (ITC). Partner Louis E. Fogel will moderate the discussion. The program will examine the use of ITC Section 337 investigations for life sciences products, including pharmaceuticals and medical devices. The presenters will cover important issues arising in such cases, including the use of public interest factors, indirect infringement, design around alternatives, the substantive elements of proof, and the procedure used by the ITC in these types of investigations. The program will begin at 12 pm ET. Please email dl_webinar@jenner.com if you are interested in attending. Space is limited. Mr. Davis is co-chair of the ITC Section 337 Practice. He represents multinational, domestic, and start-up companies regarding intellectual property and related international trade, data privacy, unfair competition, and antitrust matters. He has litigated disputes before US district courts throughout the country and the Court of Appeals for the Federal Circuit and has been involved in more than 100 section 337 investigations before the ITC. Mr. Fogel is co-chair of the Life Sciences Practice and a member of the Patent Litigation and Counseling Practice. He represents clients on a range of intellectual property matters, with an emphasis on patent and trade secret litigation. Mr. Fogel’s litigation experience spans a wide array of technologies and industries, including biological drugs, pharmaceuticals, medical devices, chemicals, consumer electronics, and telecommunications. Mr. Pabis is co-chair of the ITC Section 337 Practice. He represents technology companies in patent litigation and patent licensing disputes at all stages of the litigation process. In addition, he has handled and tried a number of Section 337 investigation hearings before the ITC. Ms. O’Brien is an associate in the firm’s Litigation Department and the Patent Litigation and Counseling Practice.

News and Insights

Podcasts

Partner Laurel Loomis Rimon Discusses Fintech Enforcement, Debanking, and Regulatory Risk on Fintech Layer Cake Podcast

Partner Laurel Loomis Rimon was featured on the Fintech Layer Cake podcast, where she discussed how fintech enforcement and prosecution actually work in practice, and what exposes fintechs and banks to regulatory risk.

July 15, 2026

Publications

Supreme Court Clarifies Scope of Private Rights of Action Under the Investment Company Act, Private Equity Law Report

Partners Charles Riely, Todd C. Toral, and Martin Glass authored a guest article for Private Equity Law Report examining the US Supreme Court's June 11, 2026, ruling on the scope of private rights of action under the Investment Company Act of 1940.

July 14, 2026

Publications

Emily Loeb Discusses Congressional Oversight Preparedness in Bloomberg Law

Partner Emily Loeb, co-chair of Jenner & Block's Congressional Investigations Practice, spoke with Bloomberg Law article about how companies can prepare for potential oversight exposure ahead of this fall's midterm elections.

July 7, 2026

Publications

In New York Law Journal, The True Lender Doctrine and the OppFi Decision

Partners Jeremy Creelan, Michael Ross, Megan Poetzel, and Laurel Loomis Rimon, and Associate Molly Oberstein-Allen authored an article for the New York Law Journal examining the "True Lender" doctrine in light of a May 2026 California decision that provides the most detailed judicial framework to date for evaluating bank-nonbank lending partnerships.

July 1, 2026

Event

Partner Michael Vernick to Speak at NACUA's 2026 Annual Conference

On July 1, Partner Michael Vernick will speak on a panel at the National Association of College and University Attorneys (NACUA) 2026 Annual Conference in Nashville.

July 1, 2026